lamotrigine has been researched along with Nervous System Diseases in 11 studies
Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To correlate lamotrigine (LTG) serum concentrations (levels) with tolerability in patients with epilepsy." | 8.82 | Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy. ( Adams, DJ; Bazil, CW; Buchsbaum, R; Du, Y; Hager, M; Hirsch, LJ; Morrell, MJ; Resor, SR; Spencer, HT; Straka, T; Weintraub, D, 2004) |
| "Lamotrigine is a broad-spectrum antiepileptic drug, initially approved in 1994 for the adjunctive treatment of partial seizures in adults and for the generalized seizures of Lennox-Gastaut syndrome in pediatric (>2 years old) and adult populations." | 6.43 | Lamotrigine and its applications in the treatment of epilepsy and other neurological and psychiatric disorders. ( Arif, H; Hirsch, LJ; Malik, S, 2006) |
| "To correlate lamotrigine (LTG) serum concentrations (levels) with tolerability in patients with epilepsy." | 4.82 | Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy. ( Adams, DJ; Bazil, CW; Buchsbaum, R; Du, Y; Hager, M; Hirsch, LJ; Morrell, MJ; Resor, SR; Spencer, HT; Straka, T; Weintraub, D, 2004) |
| "Lamotrigine is a broad-spectrum antiepileptic drug, initially approved in 1994 for the adjunctive treatment of partial seizures in adults and for the generalized seizures of Lennox-Gastaut syndrome in pediatric (>2 years old) and adult populations." | 2.43 | Lamotrigine and its applications in the treatment of epilepsy and other neurological and psychiatric disorders. ( Arif, H; Hirsch, LJ; Malik, S, 2006) |
| "Neuropathic cranial pain, i." | 2.42 | Neuropathic cranial pain. ( Annovazzi, PO; Colombo, B; Comi, G, 2003) |
| "Gabapentin has demonstrated efficacy, specifically in painful diabetic neuropathy and postherpetic neuralgia." | 2.41 | Use of anticonvulsants for treatment of neuropathic pain. ( Backonja, MM, 2002) |
| "Individuals treated with combined valproate-lamotrigine rarely present late adverse effects (unrelated to introduction and titration)." | 1.38 | Late adverse effects of the coadministration of valproate and lamotrigine. ( Moreira, B; Thome-Souza, S; Valente, KD, 2012) |
| " Concerning pharmacokinetic drug interactions, we conclude that lamotrigine can be safely combined with most psychotropic drugs." | 1.33 | Drug interactions between lamotrigine and psychoactive drugs: evidence from a therapeutic drug monitoring service. ( Reimers, A; Skogvoll, E; Spigset, O; Sund, JK, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okumura, A | 1 |
| Arai, E | 1 |
| Kitamura, Y | 1 |
| Abe, S | 1 |
| Ikeno, M | 1 |
| Fujimaki, T | 1 |
| Yamamoto, T | 1 |
| Shimizu, T | 1 |
| Reimers, A | 2 |
| Thome-Souza, S | 1 |
| Moreira, B | 1 |
| Valente, KD | 1 |
| Backonja, MM | 1 |
| Colombo, B | 1 |
| Annovazzi, PO | 1 |
| Comi, G | 1 |
| Hirsch, LJ | 2 |
| Weintraub, D | 1 |
| Du, Y | 1 |
| Buchsbaum, R | 1 |
| Spencer, HT | 1 |
| Hager, M | 1 |
| Straka, T | 1 |
| Bazil, CW | 1 |
| Adams, DJ | 1 |
| Resor, SR | 1 |
| Morrell, MJ | 1 |
| Skogvoll, E | 1 |
| Sund, JK | 1 |
| Spigset, O | 1 |
| Malik, S | 1 |
| Arif, H | 1 |
| Moncada, CR | 1 |
| Arvin, B | 1 |
| Meldrum, BS | 1 |
| Schulz, JB | 1 |
| Matthews, RT | 1 |
| Henshaw, DR | 1 |
| Beal, MF | 1 |
| Devulder, J | 1 |
| De Laat, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study of Prophylactic Management of Lamotrigine for Bipolar Disorder in Pregnant Women[NCT03774641] | 20 participants (Anticipated) | Observational | 2018-12-03 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for lamotrigine and Nervous System Diseases
| Article | Year |
|---|---|
Use of anticonvulsants for treatment of neuropathic pain.
Topics: Acetates; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; | 2002 |
Neuropathic cranial pain.
Topics: Acetates; Amines; Analgesics; Analgesics, Non-Narcotic; Anticonvulsants; Antidepressive Agents, Tric | 2003 |
Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy.
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Drug Eruptions; Drug Interactions; Drug Therapy, | 2004 |
Lamotrigine and its applications in the treatment of epilepsy and other neurological and psychiatric disorders.
Topics: Anticonvulsants; Antimanic Agents; Dose-Response Relationship, Drug; Epilepsy; Humans; Lamotrigine; | 2006 |
7 other studies available for lamotrigine and Nervous System Diseases
| Article | Year |
|---|---|
Epilepsy phenotypes in siblings with Norrie disease.
Topics: Anticonvulsants; Blindness; Chromosomes, Human, X; Electroencephalography; Epilepsy; Eye Proteins; G | 2015 |
Trends and changes in the clinical use of lamotrigine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Child; Child, Preschool; Databases, Fac | 2009 |
Late adverse effects of the coadministration of valproate and lamotrigine.
Topics: Adolescent; Anticonvulsants; Ataxia; Child; Drug Therapy, Combination; Epilepsy; Female; Headache; H | 2012 |
Drug interactions between lamotrigine and psychoactive drugs: evidence from a therapeutic drug monitoring service.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Drug Interactions; Drug Mo | 2005 |
The pyrimidine derivative BW 1003C87 protects against excitotoxic lesions induced by kainate in the rat striatum.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Hippocampus; Kai | 1994 |
Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Anticonvulsants; Coenzymes; Cyclic N-Oxides; Dizocilpine Malea | 1996 |
Lamotrigine in the treatment of chronic refractory neuropathic pain.
Topics: Adult; Aged; Analgesics; Analgesics, Opioid; Chronic Disease; Drug Therapy, Combination; Female; Hum | 2000 |